Literature DB >> 11771748

The brain in Down syndrome.

R Seidl1, N Cairns, G Lubec.   

Abstract

Down syndrome (trisomy 21) is a genetic disease with developmental brain abnormalities resulting in early mental retardation and precocious, age dependent Alzheimer-type neurodegeneration. We tried to discuss the role of neurodevelopmental abnormalities in connection with aberrant expression of genes on chromosome 21 including amyloid precursor protein (APP), CuZn superoxide dismutase (SOD1) and glial-derived S100 beta protein for neurodegeneration in DS. In this model, alterations in developmental pathways due to aberrant gene expression can impair cellular homeostasis and predispose to neurodegeneration of certain brain regions and types of nerve cells, involving cholinergic, serotonergic and catecholaminergic transmission, by shifting balance toward a pro-apoptotic state.

Entities:  

Mesh:

Year:  2001        PMID: 11771748     DOI: 10.1007/978-3-7091-6262-0_20

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  4 in total

Review 1.  Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.

Authors:  Marzia Perluigi; Fabio Di Domenico; D Allan Buttterfield
Journal:  Proteomics Clin Appl       Date:  2014-02       Impact factor: 3.494

2.  Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.

Authors:  Antonella Tramutola; Gilda Pupo; Fabio Di Domenico; Eugenio Barone; Andrea Arena; Chiara Lanzillotta; Diede Brokeaart; Carla Blarzino; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 3.  Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?

Authors:  Greg T Sutherland; Belal Chami; Priscilla Youssef; Paul K Witting
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

4.  Combined Treatment With Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome.

Authors:  Silvina Catuara-Solarz; Jose Espinosa-Carrasco; Ionas Erb; Klaus Langohr; Juan Ramon Gonzalez; Cedric Notredame; Mara Dierssen
Journal:  eNeuro       Date:  2016-11-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.